| scholarly article | Q13442814 |
| P2093 | author name string | McKay C | |
| Weber L | |||
| Elkayam U | |||
| Rahimtoola S | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| hemodynamics | Q1642137 | ||
| congestive heart failure | Q19000661 | ||
| nifedipine | Q39111 | ||
| P304 | page(s) | 560-566 | |
| P577 | publication date | 1985-09-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. | |
| P478 | volume | 56 |
| Q39685266 | 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications |
| Q59684591 | A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension |
| Q54249241 | Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. |
| Q36699356 | Calcium Antagonists in Patients with Heart Failure |
| Q38952140 | Calcium antagonists and chronic cardiac failure |
| Q38603876 | Calcium antagonists and heart failure. |
| Q41715204 | Calcium channel blocker-induced protection against cardiovascular damage |
| Q41500182 | Cardiac effects of calcium antagonists in systemic hypertension |
| Q69894427 | Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure |
| Q68429425 | Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue |
| Q36829539 | Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure |
| Q78015360 | Effects of mebudipine and dibudipine, two new calcium-channel blockers, on rat left atrium, rat blood pressure and human internal mammary artery |
| Q41870229 | Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure. |
| Q72992813 | Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure |
| Q68704398 | Negative inotropic effect of intravenous nifedipine in coronary artery disease: relation to plasma levels |
| Q38631176 | Nicardipine, a new calcium channel blocker: role for vascular selectivity |
| Q34159658 | Observation unit management of heart failure |
| Q36970461 | Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine |
| Q68204869 | Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction |
| Q43810304 | Radionuclide monitoring of left ventricular function after sublingual nifedipine administration at rest and during moderate physical activity |
| Q41653547 | Safety of calcium antagonists in patients with congestive heart failure |
| Q54347545 | Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy. |
| Q37579772 | Stable angina pectoris: 3. Medical treatment |
| Q38215916 | Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations |
| Q54420898 | [Calcium antagonists in heart failure?]. |
Search more.